• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

混合模式和反相液相色谱-串联质谱法研究聚山梨酯 20 和 80 的组成和碱基水解。

Mixed-mode and reversed-phase liquid chromatography-tandem mass spectrometry methodologies to study composition and base hydrolysis of polysorbate 20 and 80.

机构信息

Department of Protein Analytical Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080-4990, USA.

出版信息

J Chromatogr A. 2011 Apr 15;1218(15):2138-45. doi: 10.1016/j.chroma.2010.09.057. Epub 2010 Sep 29.

DOI:10.1016/j.chroma.2010.09.057
PMID:20950816
Abstract

Polysorbate 20 (polyoxyethylenesorbitan monolaurate) and polysorbate 80 (polyoxyethylenesorbitan monooleate) used in protein drug formulations are complex mixtures that have been difficult to characterize. Here, two HPLC methods are used with evaporative light scattering detection (ELSD) and mass spectrometry (MS) to characterize polysorbate from commercial vendors. The first HPLC method used a mixed-mode stationary phase (Waters Oasis MAX, mixed-mode anion exchange and reversed-phase sorbent) with a step gradient to quantify both the total polyoxyethylene sorbitan ester and polyoxyethylene sorbitan (POE sorbitan, a non-surfactant) in polysorbate. The results indicated POE sorbitan was present from 16.0 to 27.6 and 11.1 to 14.5% (w/w) in polysorbate 20 and 80, respectively. The second HPLC method used a reversed-phase stationary phase (Zorbax SB-300 C(8)) with a shallow gradient to separate, identify, and quantify the multiple ester species present in polysorbate. For all lots of polysorbate 20 analyzed, only 18-23% of the material was the expected structure, polyoxyethylenesorbitan monolaurate. Up to 40% and 70% (w/w) di- and triesters were found in polysorbate 20 and polysorbate 80 respectively. Likewise, polyoxyethylenesorbitan monooleate accounted for only 20% of polysorbate 80. A variability of 3-5% was observed for each ester species between multiple lots of polysorbate 20. The reversed-phase method was then used to determine the rate of hydrolysis for each polyoxyethylene sorbitan ester of polysorbate 20 in basic solution at room temperature. Increasing rates of hydrolysis were observed with decreasing aliphatic chain lengths in polysorbate 20.

摘要

聚山梨酯 20(聚氧乙烯山梨醇单月桂酸酯)和聚山梨酯 80(聚氧乙烯山梨醇单油酸酯)用于蛋白质药物制剂,它们是复杂的混合物,难以进行表征。在这里,我们使用两种高效液相色谱法(HPLC)与蒸发光散射检测(ELSD)和质谱(MS)相结合,对来自商业供应商的聚山梨酯进行了表征。第一种 HPLC 方法使用混合模式固定相(Waters Oasis MAX,混合模式阴离子交换和反相固定相),采用逐步梯度,定量测定聚山梨酯中的总聚氧乙烯山梨醇酯和聚氧乙烯山梨醇(非表面活性剂 POE 山梨醇)。结果表明,聚山梨酯 20 中的 POE 山梨醇含量为 16.0%至 27.6%(w/w),聚山梨酯 80 中的 POE 山梨醇含量为 11.1%至 14.5%(w/w)。第二种 HPLC 方法使用反相固定相(Zorbax SB-300 C(8)),采用浅梯度,分离、鉴定和定量聚山梨酯中存在的多种酯类物质。对所有分析的聚山梨酯 20 批次,只有 18-23%的物质是预期的结构,即聚氧乙烯山梨醇单月桂酸酯。在聚山梨酯 20 和聚山梨酯 80 中,分别发现了高达 40%和 70%(w/w)的二酯和三酯。同样,聚氧乙烯山梨醇单油酸酯在聚山梨酯 80 中仅占 20%。在多个批次的聚山梨酯 20 之间,每种酯类物质的差异为 3-5%。然后,使用反相方法在室温碱性溶液中测定聚山梨酯 20 中每种聚氧乙烯山梨醇酯的水解速率。随着聚山梨酯 20 中脂肪链长度的降低,水解速率逐渐增加。

相似文献

1
Mixed-mode and reversed-phase liquid chromatography-tandem mass spectrometry methodologies to study composition and base hydrolysis of polysorbate 20 and 80.混合模式和反相液相色谱-串联质谱法研究聚山梨酯 20 和 80 的组成和碱基水解。
J Chromatogr A. 2011 Apr 15;1218(15):2138-45. doi: 10.1016/j.chroma.2010.09.057. Epub 2010 Sep 29.
2
Analysis of polysorbate 80 and its related compounds by RP-HPLC with ELSD and MS detection.采用带蒸发光散射检测器(ELSD)和质谱(MS)检测的反相高效液相色谱法(RP-HPLC)分析聚山梨酯80及其相关化合物。
J Chromatogr Sci. 2012 Aug;50(7):598-607. doi: 10.1093/chromsci/bms035. Epub 2012 Apr 26.
3
Quantitation of polysorbate 20 in protein solutions using mixed-mode chromatography and evaporative light scattering detection.使用混合模式色谱法和蒸发光散射检测法对蛋白质溶液中的聚山梨酯20进行定量分析。
J Chromatogr A. 2008 Dec 26;1215(1-2):156-60. doi: 10.1016/j.chroma.2008.11.017. Epub 2008 Nov 14.
4
A simple reversed phase high-performance liquid chromatography method for polysorbate 80 quantitation in monoclonal antibody drug products.一种简单的反相高效液相色谱法,用于单克隆抗体药物产品中聚山梨酯 80 的定量分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Jul 1;878(21):1865-70. doi: 10.1016/j.jchromb.2010.04.039. Epub 2010 May 4.
5
Impact of mono- and poly-ester fractions on polysorbate quantitation using mixed-mode HPLC-CAD/ELSD and the fluorescence micelle assay.单酯和多酯级分对采用混合模式高效液相色谱-蒸发光散射检测器/蒸发光散射检测器和荧光胶束分析法进行聚山梨酯定量分析的影响。
J Pharm Biomed Anal. 2017 Jan 5;132:24-34. doi: 10.1016/j.jpba.2016.09.033. Epub 2016 Sep 26.
6
Characterization of polysorbate 80 with liquid chromatography mass spectrometry and nuclear magnetic resonance spectroscopy: specific determination of oxidation products of thermally oxidized polysorbate 80.采用液相色谱-质谱联用和核磁共振波谱法对聚山梨酯 80 进行表征:热氧化聚山梨酯 80 氧化产物的特异性测定。
J Pharm Biomed Anal. 2012 Mar 25;62:7-16. doi: 10.1016/j.jpba.2011.12.009. Epub 2011 Dec 17.
7
Simultaneous determination of polysorbate 20 and unbound polyethylene-glycol in protein solutions using new core-shell reversed phase column and condensation nucleation light scattering detection.采用新型核壳反相色谱柱和凝聚核光散射检测法同时测定蛋白质溶液中的聚山梨酯 20 和未结合的聚乙二醇。
J Chromatogr A. 2010 Oct 1;1217(40):6258-66. doi: 10.1016/j.chroma.2010.08.028. Epub 2010 Aug 13.
8
Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.多维超高效液相色谱-电喷雾检测-质谱法分析治疗性单克隆抗体制剂中聚山梨酯 20 的特性和稳定性。
Anal Chem. 2014 May 20;86(10):5150-7. doi: 10.1021/ac5009628. Epub 2014 May 2.
9
The composition of NF-defined emulsifiers: sorbitan monolaurate, monopalmitate, monostearate, monooleate, polysorbate 20, polysorbate 40, polysorbate 60, and polysorbate 80.NF定义的乳化剂的组成:脱水山梨醇单月桂酸酯、单棕榈酸酯、单硬脂酸酯、单油酸酯、聚山梨醇酯20、聚山梨醇酯40、聚山梨醇酯60和聚山梨醇酯80。
Drug Dev Ind Pharm. 1998 Nov;24(11):1049-54. doi: 10.3109/03639049809089948.
10
Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways.用于蛋白质生物治疗药物制剂的聚山梨酯20和80:结构与降解途径
J Pharm Sci. 2008 Aug;97(8):2924-35. doi: 10.1002/jps.21190.

引用本文的文献

1
Validation, measurement uncertainty, and determination of polysorbate-labeled foods distributed in Korea.韩国销售的聚山梨酯标记食品的验证、测量不确定度及测定
Food Sci Biotechnol. 2024 Mar 18;33(12):2747-2754. doi: 10.1007/s10068-024-01544-w. eCollection 2024 Sep.
2
High-Throughput Fluorometric Assay For Quantifying Polysorbate In Biopharmaceutical Products Using Micelle Activated Fluorescence Probe N-Phenyl-1-Naphthylamine.基于胶束增敏荧光探针 N-苯基-1-萘胺的高通量荧光法测定生物制药产品中聚山梨酯 80 的含量
Pharm Res. 2024 Jul;41(7):1455-1473. doi: 10.1007/s11095-024-03723-0. Epub 2024 Jul 2.
3
Discrimination of polysorbate 20 by high-performance liquid chromatography-charged aerosol detection and characterization for components by expanding compound database and library.
通过高效液相色谱-带电气溶胶检测法鉴别聚山梨醇酯20,并通过扩展化合物数据库和谱库对其成分进行表征。
J Pharm Anal. 2024 May;14(5):100929. doi: 10.1016/j.jpha.2023.12.019. Epub 2023 Dec 30.
4
Comparative Stability Study of Polysorbate 20 and Polysorbate 80 Related to Oxidative Degradation.聚山梨醇酯20和聚山梨醇酯80与氧化降解相关的稳定性比较研究
Pharmaceutics. 2023 Sep 16;15(9):2332. doi: 10.3390/pharmaceutics15092332.
5
Oxidation of polysorbates - An underestimated degradation pathway?聚山梨酯的氧化——一种被低估的降解途径?
Int J Pharm X. 2023 Jul 27;6:100202. doi: 10.1016/j.ijpx.2023.100202. eCollection 2023 Dec 15.
6
Alternative Excipients for Protein Stabilization in Protein Therapeutics: Overcoming the Limitations of Polysorbates.蛋白质治疗药物中用于蛋白质稳定化的替代辅料:克服聚山梨酯的局限性
Pharmaceutics. 2022 Nov 23;14(12):2575. doi: 10.3390/pharmaceutics14122575.
7
A Mechanistic Understanding of Monoclonal Antibody Interfacial Protection by Hydrolytically Degraded Polysorbate 20 and 80 under IV Bag Conditions.在 IV 袋条件下,通过水解降解的聚山梨酯 20 和 80 对单克隆抗体界面保护的机理理解。
Pharm Res. 2022 Mar;39(3):563-575. doi: 10.1007/s11095-022-03217-x. Epub 2022 Mar 11.
8
Evaluating a Modified High Purity Polysorbate 20 Designed to Reduce the Risk of Free Fatty Acid Particle Formation.评估一种改良的高纯度聚山梨酯 20,旨在降低游离脂肪酸颗粒形成的风险。
Pharm Res. 2021 Sep;38(9):1563-1583. doi: 10.1007/s11095-021-03087-9. Epub 2021 Sep 8.
9
Shape and Structure Formation of Mixed Nonionic-Anionic Surfactant Micelles.混合非离子-阴离子表面活性剂胶束的形状与结构形成
Molecules. 2021 Jul 7;26(14):4136. doi: 10.3390/molecules26144136.
10
A Comprehensive Assessment of All-Oleate Polysorbate 80: Free Fatty Acid Particle Formation, Interfacial Protection and Oxidative Degradation.全油酸聚山梨酯 80 的综合评估:游离脂肪酸粒子形成、界面保护和氧化降解。
Pharm Res. 2021 Mar;38(3):531-548. doi: 10.1007/s11095-021-03021-z. Epub 2021 Mar 12.